Patents by Inventor William K. Chan

William K. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8767838
    Abstract: A system (and a method) are disclosed for a video processing system cascading multiple transcoders. The system includes a first transcoder, a second transcoder and an optional third transcoder. The first transcoder is a pre-processing transcoder configured to preprocess an input video stream into a first bitstream in a first video format. The second transcoder is a primary transcoder configured to transcode the first bitstream into a second bitstream in a second video format. The third transcoder comprises a post-processing transcoder configured to further transcode the second bitstream into a third bitstream in a third video format. Pre-processing and post-processing the input video stream by the cascaded transcoders allows the system to more efficiently and quickly transcode the input video stream. Pre-processing and post-processing the input video further improves processing efficiency and speed and also increases throughout of coding processing.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: July 1, 2014
    Assignee: Zenverge, Inc.
    Inventors: Jun Xin, Behzad R. Sayyah, William K. Chan
  • Patent number: 8669264
    Abstract: The teachings provided herein generally relate to compositions comprising rutaecarpine derivatives that activates CYP1A2 through enzyme induction. The uses for such a derivative can include removing caffeine from a subject, improving sleep, treating insomnia, treating caffeine toxicity, treating caffeine addiction and withdrawal symptoms, and the like. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: March 11, 2014
    Assignee: Linnet Biopharmaceuticals, Inc.
    Inventors: Liang Xue, William K. Chan, Stan W. Linnet, Timothy N. Linnet
  • Publication number: 20120322812
    Abstract: The teachings provided herein generally relate to compositions comprising a rutaecarpine derivative that activates CYP1A2 through enzyme induction. The uses for such a derivative, in some embodiments can include improving sleep, as well as treating insomnia. Other uses for the derivatives are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: Stan W. Linnet, Timothy N. Linnet, William K. Chan, Liang Xue
  • Publication number: 20120322813
    Abstract: The teachings provided herein generally relate to compositions comprising a rutaecarpine derivative that activates CYP1A2 through enzyme induction. The compound can be used for treating caffeine toxicity, in some embodiments. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: Timothy N. Linnet, Stan W. Linnet, William K. Chan, Liang Xue
  • Publication number: 20120322816
    Abstract: The teachings provided herein generally relate to compositions comprising rutaecarpine derivatives that activates CYP1A2 through enzyme induction. The uses for such a derivative can include removing caffeine from a subject, improving sleep, treating insomnia, treating caffeine toxicity, treating caffeine addiction and withdrawal symptoms, and the like. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: LIANG XUE, William K. Chan, Stan W. Linnet, Timothy N. Linnet
  • Patent number: 7009604
    Abstract: One embodiment of a method of frame detection may involve storing data indicative of a pulse duration and a number of successive occurrences of pulses having that pulse duration for each of several different pulse durations detected within a first field of a composite synchronization signal. This process may be repeated for one or more other fields of the composite synchronization signal. The data stored for each of the fields may be compared, and a frame signal may be generated dependent on an outcome of said comparing.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: March 7, 2006
    Assignee: Sun Microsystems, Inc.
    Inventors: William K. Chan, Nathaniel David Naegle
  • Publication number: 20040012612
    Abstract: One embodiment of a method of frame detection may involve storing data indicative of a pulse duration and a number of successive occurrences of pulses having that pulse duration for each of several different pulse durations detected within a first field of a composite synchronization signal. This process may be repeated for one or more other fields of the composite synchronization signal. The data stored for each of the fields may be compared, and a frame signal may be generated dependent on an outcome of said comparing.
    Type: Application
    Filed: July 19, 2002
    Publication date: January 22, 2004
    Inventors: William K. Chan, Nathaniel David Naegle